Intensity Modulated Arc Therapy in Bilaterally Irradiated Head and Neck Cancer: A Comparative and Prospective Multicenter Planning Study

REFERENCES

• Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009;74(1):1–8.
   PubMed Web of Science ®Google Scholar
• van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, Lamers EA, Balm AJ, Rasch CR. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008;3:41.
   PubMed Web of Science ®Google Scholar
• Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127–136.
   PubMed Web of Science ®Google Scholar
• Toledano I, Graff P, Serre A, Boisselier P, Bensadoun RJ, Ortholan C, Pommier P, Racadot S, Calais G, Alfonsi M, Favrel V, Giraud P, Lapeyre M. Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03. Radiother Oncol 2012;103(1):57–62.
   PubMed Web of Science ®Google Scholar
• Marcié SAP, Lefkopoulos D, Tomsej M. Quality assurance program for intensity-modulated radiotherapy (ILRT) treatments of head and neck carcinomas. Cancer Radiother. 2003;7:172–178.
   PubMedGoogle Scholar
• Lapeyre MHP, Zlfonsi M, Bardet E, Bensadoun RJ, Dolivet G, Favrel V, Gallocher O, Giraud P, Graff P, Guerif S, Lagarde P, Lartigau E, Marchesi V, Pommier P, Rives M, Tortochaux J, Toussaint B, Verrelle P, Bourhis J, Calais G. Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded). Cancer Radiother. 2005;9:261–270.
   PubMedGoogle Scholar
• Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys. 2002;53(5):1174–1184.
   PubMed Web of Science ®Google Scholar
• Eisbruch AFR, O'Sullivan B, Beitler J, Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002;12:238–249.
   PubMed Web of Science ®Google Scholar
• Gregoire VCE, Cosnard G, Hamoir M, Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000;56:135–150.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measurements: ICRU Report 83. Prescribing, Recording and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT). J ICRU 2010;10(1).
   Google Scholar
• Chao KSDJ, Markman J, Haynie J, Perez C, Purdy J, Low D. A prospective study of salivary function sparing in patients with Head and Neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49(4):907–916.
   PubMed Web of Science ®Google Scholar
• Feuvret L, Noel G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006;64(2):333–342.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl.):S58–S63.
   PubMed Web of Science ®Google Scholar
• D'Souza WD, Rosen, II. Nontumor integral dose variation in conventional radiotherapy treatment planning. Med Phys 2003;30(8):2065–2071.
   PubMed Web of Science ®Google Scholar
• Servagi Vernat S, Ali D, Puyraveau M, Viard R, Lisbona A, Fenoglietto P, Bedos L, Makovicka L, Giraud P. Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of Helical TomoTherapy and Volumetric Modulated Arc Therapy for Oropharyngeal cancer in a planning study. Phys Med 2013; in press.
   PubMed Web of Science ®Google Scholar
• Van Gestel D, Vliet-Vroegindeweij C, Van den Heuvel F, Crijns W, Coelmont A, De Ost B, Holt An, Lamers E, Geussens Y, Nuyts S, Van den Weyngaert D, Van den Wyngaert T, Vermoken J, Gregoire V. Rapid Arc, Smart Arc and Tomo HD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison. Radiat Oncol 2013;8(37):1–11.
   PubMedGoogle Scholar
• Sheng KMJ, Larner J, Read P. A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol 2007;82:174–178.
   PubMed Web of Science ®Google Scholar
• Vanetti EN G, Nord, J, Peltola J, Clivio A, Fogliata A, Cozzi L. On the role of the optimization algorithm of RapidArc volumetric modulated arc therapy on plan quality and efficiency. Med Phys 2011;38:5844–5856.
   PubMed Web of Science ®Google Scholar
• Bedfort J. Treatment planning for volumetric modulated arc therapy. Med Phys 2009;36:5128–5138.
   PubMed Web of Science ®Google Scholar
• Tomsej M. The TomoTherapy Hi Art System for sophisticated IMRT and IGRT with helical delivery: recent developments and clinical applications. Cancer Radiother 2006;10:288–295.
   PubMedGoogle Scholar
• Mackie TR, Holmes T, Swerdloff S, Reckwerdt P, Deasy JO, Yang J, Paliwal B, Kinsella T. Tomotherapy: a new concept for the delivery of conformal radiotherapy. Med Phys 1993;20(6):1709–1719.
   PubMed Web of Science ®Google Scholar
• Clemente S, Wu B, Sanguineti G, Fusco V, Ricchetti F, Wong J, McNutt T. SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy. Int J Radiat Oncol Biol Phys 2011;80(4):1248–1255.
   PubMed Web of Science ®Google Scholar
• Lu SH, Cheng JC, Kuo SH, Lee JJ, Chen LH, Wu JK, Chen YH, Chen WY, Wen SY, Chong FC, Wu CJ, Wang CW. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol 2012;104(3):324–330.
   PubMed Web of Science ®Google Scholar
• Oliver M, Ansbacher W, Beckham WA. Comparing planning time, delivery time and plan quality for IMRT, RapidArc and Tomotherapy [Abstract]. J Appl Med Phys 2009;10:3068.
   Google Scholar
• Rochet N, Jensen AD, Sterzing F, Munter MW, Eichbaum MH, Schneeweiss A, Sohn C, Debus J, Harms W. Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01)—Pilot trial of a phase I/II study: study protocol. BMC Cancer 2007;7(227):1–7.
   PubMedGoogle Scholar
• Sterzing F, Sroka-Perez G, Schubert K, Munter MW, Thieke C, Huber P, Debus J, Herfarth KK. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT. Radiother Oncol 2008;86(2):251–257.
   PubMed Web of Science ®Google Scholar
• Vanetti E, Clivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal JP, Upreti RR, Budrukkar A, Murthy V, Deshpande DD, Shrivastava SK, Dinshaw KA, Cozzi L. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol 2009;92(1):111–117.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Dell'Oca I, Pierelli A, Broggi S, De Martin E, Di Muzio N, Longobardi B, Fazio F, Calandrino R. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 2006;78(3):276–282.
   PubMed Web of Science ®Google Scholar
• Verellen D.VF. Risk assessment of radiation-induced malignancies based on whole body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53:199–203.
   PubMed Web of Science ®Google Scholar
• Rao M, Yang W, Chen F, Sheng K, Ye J, Mehta V, Shepard D, Cao D. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: plan quality, delivery efficiency and accuracy. Med Phys 2010;37(3):1350–1359.
   PubMed Web of Science ®Google Scholar
• Widesott L, Pierelli A, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, Di Muzio N, Fazio F, Calandrino R, Schwarz M. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008;72(2):589–596.
   PubMed Web of Science ®Google Scholar
• Simone CB 2nd. LD, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL. Comparison of intensity modulated radiotherapy, adaptative radiotherapy, proton therapy and adaptative proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol 2011;101(3): 376–382.
   PubMed Web of Science ®Google Scholar